On the public citation graph

Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux

https://doi.org/10.1007/s00405-018-5079-0
0 signed · 78 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 28 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-21): 10.1002/14651858.cd005054.pub2 (notice 2015-04-15).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamaneurol.2015.4791openalex-snapshot
Association of Proton Pump Inhibitors With Risk of Dementia
inferredcites →https://doi.org/10.1002/14651858.cd004823.pub4openalex-snapshot
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults
inferredcites →https://doi.org/10.1002/14651858.cd005054.pub2openalex-snapshot
Acid reflux treatment for hoarseness
inferredcites →https://doi.org/10.1002/14651858.cd005054.pub3openalex-snapshot
Acid reflux treatment for hoarseness
inferredcites →https://doi.org/10.1002/lary.1991.101.s53.1openalex-snapshot
The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24‐Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal Injury
inferredcites →https://doi.org/10.1002/lary.23693openalex-snapshot
Mucosal changes in laryngopharyngeal reflux—prevalence, sensitivity, specificity and assessment
inferredcites →https://doi.org/10.1002/lary.24483openalex-snapshot
Incidence of underlying laryngeal pathology in patients initially diagnosed with laryngopharyngeal reflux
inferredcites →https://doi.org/10.1007/s00405-006-0222-8openalex-snapshot
Trends in laryngopharyngeal reflux: a British ENT survey
inferredcites →https://doi.org/10.1007/s00405-008-0708-7openalex-snapshot
The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux
inferredcites →https://doi.org/10.1007/s00405-016-4142-yopenalex-snapshot
A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux
inferredcites →https://doi.org/10.1016/j.cgh.2011.09.030openalex-snapshot
Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis
inferredcites →https://doi.org/10.1016/s0892-1997(02)00097-8openalex-snapshot
Validity and Reliability of the Reflux Symptom Index (RSI)
inferredcites →https://doi.org/10.1053/s1542-3565(03)00177-0openalex-snapshot
Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association
inferredcites →https://doi.org/10.1067/mhn.2002.125760openalex-snapshot
Laryngopharyngeal Reflux: Position Statement of the Committee on Speech, Voice, and Swallowing Disorders of the American Academy of Otolaryngology‐Head and Neck Surgery
inferredcites →https://doi.org/10.1080/14015430902735847openalex-snapshot
Prevalence of symptoms suggestive of extra-oesophageal reflux in a general practice population in the UK
inferredcites →https://doi.org/10.1097/01.mlg.0000163746.81766.45openalex-snapshot
Laryngopharyngeal Reflux: Prospective Cohort Study Evaluating Optimal Dose of Proton-Pump Inhibitor Therapy and Pretherapy Predictors of Response
inferredcites →https://doi.org/10.1097/moo.0b013e32832b2581openalex-snapshot
Laryngopharyngeal reflux: current concepts and questions
inferredcites →https://doi.org/10.1111/j.1365-2036.2006.03213.xopenalex-snapshot
Meta‐analysis: the efficacy of proton pump inhibitors for laryngeal symptoms attributed to gastro‐oesophageal reflux disease
inferredcites →https://doi.org/10.1111/j.1572-0241.2006.00844.xopenalex-snapshot
Proton Pump Inhibitor Therapy for Suspected GERD-Related Chronic Laryngitis: A Meta-Analysis of Randomized Controlled Trials
inferredcites →https://doi.org/10.1111/j.1749-4486.2011.02394.xopenalex-snapshot
Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it
inferredcites →https://doi.org/10.1111/j.1749-4486.2012.02443.xopenalex-snapshot
Extra‐oesophageal reflux: state of the knowledge base
inferredcites →https://doi.org/10.1136/bmj.39406.449456.beopenalex-snapshot
Overprescribing proton pump inhibitors
inferredcites →https://doi.org/10.1136/bmj.g5813openalex-snapshot
Are persistent throat symptoms atypical features of gastric reflux and should they be treated with proton pump inhibitors?
inferredcites →https://doi.org/10.1177/0003489414525021openalex-snapshot
Symptom Overlap Between Laryngopharyngeal Reflux and Glottic Insufficiency in Vocal Fold Atrophy Patients
inferredcites →https://doi.org/10.1177/0194599816664330openalex-snapshot
Patient‐Reported Outcome Measures Related to Laryngopharyngeal Reflux
inferredcites →https://doi.org/10.1186/s13063-016-1267-7openalex-snapshot
TOPPITS: Trial Of Proton Pump Inhibitors in Throat Symptoms. Study protocol for a randomised controlled trial
inferredcites →https://doi.org/10.1586/ecp.12.20openalex-snapshot
Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis
inferredcites →https://doi.org/10.4172/2161-119x.s1-004openalex-snapshot
Laryngopharyngeal Reflux – A Randomized Clinical Controlled Trial

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4848611openalex-extracted
inferred← citeshttps://doi.org/10.1002/9781119599692.ch31openalex-snapshot
ENT Complaints in GERD
inferred← citeshttps://doi.org/10.1002/jcp.28061openalex-snapshot
RETRACTED: Circular RNA circ_0001946 acts as a competing endogenous RNA to inhibit glioblastoma progression by modulating miR‐671‐5p and CDR1
inferred← citeshttps://doi.org/10.1002/lary.28484openalex-snapshot
Do Laryngologists and General Otolaryngologists Manage Laryngopharyngeal Reflux Differently?
inferred← citeshttps://doi.org/10.1002/lary.28597openalex-snapshot
Laryngeal Mucosa Alterations in Mice Model of Gastroesophageal Reflux: Effects of Topical Protection
inferred← citeshttps://doi.org/10.1002/lary.28736openalex-snapshot
Hypopharyngeal‐Esophageal Impedance‐pH Monitoring Profiles of Laryngopharyngeal Reflux Patients
inferred← citeshttps://doi.org/10.1002/lary.29270openalex-snapshot
Management of Laryngopharyngeal Reflux Around the World: An International Study
inferred← citeshttps://doi.org/10.1002/lary.30093openalex-snapshot
Laryngeal and Esophageal Mucosal Protection Using the Angico Gum Biopolymer in a Mouse Model of Reflux
inferred← citeshttps://doi.org/10.1002/ohn.1019openalex-snapshot
Refractory Chronic Cough: A State‐of‐the‐Art Review for Otolaryngologists
inferred← citeshttps://doi.org/10.1007/978-3-030-48890-1_35openalex-snapshot
State of the Art: Laryngopharyngeal Reflux Treatment
inferred← citeshttps://doi.org/10.1007/978-3-031-22483-6_134-1openalex-snapshot
Laryngopharyngeal Reflux
inferred← citeshttps://doi.org/10.1007/s00106-023-01280-3openalex-snapshot
Aktuelle Möglichkeiten und Herausforderungen bei der Therapie des laryngopharyngealen Refluxes
inferred← citeshttps://doi.org/10.1007/s00405-021-07201-wopenalex-snapshot
Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets
inferred← citeshttps://doi.org/10.1007/s00405-021-07219-0openalex-snapshot
Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial
inferred← citeshttps://doi.org/10.1007/s00405-025-09693-2openalex-snapshot
Alginates and laryngopharyngeal reflux: where we stand. A systematic review
inferred← citeshttps://doi.org/10.1007/s00405-026-10354-1openalex-snapshot
Comparison of the efficacy of different pharmacological treatments for laryngopharyngeal reflux: a systematic review and network meta-analysis
inferred← citeshttps://doi.org/10.1016/j.abb.2024.110129openalex-snapshot
Alginate binding enhances the structural stability and potentiates the lytic activity of bacteriophage endolysin's partially folded conformation
inferred← citeshttps://doi.org/10.1016/j.aforl.2020.02.004openalex-snapshot
Mise au point sur le reflux laryngopharyngé
inferred← citeshttps://doi.org/10.1016/j.anorl.2020.11.002openalex-snapshot
Review of management of laryngopharyngeal reflux disease
inferred← citeshttps://doi.org/10.1016/j.gtc.2021.08.002openalex-snapshot
How to Understand and Treat Laryngopharyngeal Reflux
inferred← citeshttps://doi.org/10.1016/j.imr.2020.100663openalex-snapshot
Design characteristics of comparative effectiveness trials for the relief of symptomatic dyspepsia: A systematic review
inferred← citeshttps://doi.org/10.1016/j.jvoice.2021.04.007openalex-snapshot
A New Risk of Using Alkaline Drops in Patients With Laryngopharyngeal Reflux
inferred← citeshttps://doi.org/10.1016/j.jvoice.2024.02.011openalex-snapshot
A Meta-analysis of PPIs Plus Alginate Versus PPIs Alone for the Treatment of GERD
inferred← citeshttps://doi.org/10.1016/j.jvoice.2024.04.023openalex-snapshot
Correlation of Dry Eye Disease and Laryngopharyngeal Reflux Based on Improved Symptoms With Combined Therapy
inferred← citeshttps://doi.org/10.1016/j.jvoice.2024.11.014openalex-snapshot
Pharmacological and Biological Relevance in the Medical Treatment of Laryngopharyngeal Reflux: A State-of-the-Art Review
inferred← citeshttps://doi.org/10.1016/j.jvoice.2025.03.011openalex-snapshot
Clinical Relevance and Therapeutic Findings of Chronic Cough Related to Laryngopharyngeal Reflux Disease
inferred← citeshttps://doi.org/10.1080/17474124.2022.2043744openalex-snapshot
The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)
inferred← citeshttps://doi.org/10.1097/moo.0000000000000663openalex-snapshot
What is the truth about proton pump inhibitors?
inferred← citeshttps://doi.org/10.1111/coa.13518openalex-snapshot
Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review
inferred← citeshttps://doi.org/10.1111/coa.13722openalex-snapshot
The efficacy of a personalised treatment depending on the characteristics of reflux at multichannel intraluminal impedance‐pH monitoring in patients with acid, non‐acid and mixed laryngopharyngeal reflux
inferred← citeshttps://doi.org/10.1111/nyas.14366openalex-snapshot
Proximal reflux: biochemical mediators, markers, therapeutic targets, and clinical correlations
inferred← citeshttps://doi.org/10.1111/nyas.14728openalex-snapshot
An update on current treatment strategies for laryngopharyngeal reflux symptoms
inferred← citeshttps://doi.org/10.1136/bmj.m4091openalex-snapshot
A lump in the throat: laryngopharyngeal reflux
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-087729openalex-snapshot
Trial of alginates in throat symptoms: protocol for a pragmatic, multicentre, placebo controlled, double blind, parallel, randomised controlled trial of liquid alginate (Gaviscon Advance) for the treatment of persistent throat symptoms
inferred← citeshttps://doi.org/10.1159/000514337openalex-snapshot
Phytotherapeutische Ansätze zur Behandlung des laryngopharyngealen Reflux in der HNO-Praxis
inferred← citeshttps://doi.org/10.1177/0003489420913592openalex-snapshot
A Prospective Randomized Clinical Trial of Combination Therapy with Proton Pump Inhibitors and Mucolytics in Patients with Laryngopharyngeal Reflux
inferred← citeshttps://doi.org/10.1177/0003489420922870openalex-snapshot
Alternatives to Acid Suppression Treatment for Laryngopharyngeal Reflux
inferred← citeshttps://doi.org/10.1177/0003489420930034openalex-snapshot
Assessment and Diagnostic Accuracy Evaluation of the Reflux Symptom Index (RSI) Scale: Psychometric Properties using Optimal Scaling Techniques
inferred← citeshttps://doi.org/10.1177/0194599819827488openalex-snapshot
Evaluation and Management of Laryngopharyngeal Reflux Disease: State of the Art Review
inferred← citeshttps://doi.org/10.1177/19160216251347602openalex-snapshot
Treatment for Laryngopharyngeal Reflux Disease: A Systematic Review of Controlled Studies
inferred← citeshttps://doi.org/10.12998/wjcc.v7.i19.2995openalex-snapshot
Treatment of laryngopharyngeal reflux disease: A systematic review
inferred← citeshttps://doi.org/10.21053/ceo.2020.00465openalex-snapshot
Pepsin and Laryngeal and Hypopharyngeal Carcinomas
inferred← citeshttps://doi.org/10.23736/s0031-0808.25.05387-xopenalex-snapshot
Laryngopharyngeal reflux disease: a pilot study with a new multicomponent
inferred← citeshttps://doi.org/10.31080/asms.2022.06.1409openalex-snapshot
Treatment of Laryngopharyngeal Reflux Disease Using an Oral Medical Device: A Clinical Investigation into Signs, Symptoms and Quality of Life of Patients
inferred← citeshttps://doi.org/10.3310/hta25030openalex-snapshot
Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT
inferred← citeshttps://doi.org/10.3389/fmed.2025.1488323openalex-snapshot
Efficacy of dietary modifications and mucosal protectors in the treatment of laryngopharyngeal reflux: a multicenter study
inferred← citeshttps://doi.org/10.3390/diagnostics13091643openalex-snapshot
Diagnosis of Laryngopharyngeal Reflux: Past, Present, and Future—A Mini-Review
inferred← citeshttps://doi.org/10.3390/jcm11071890openalex-snapshot
The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease
inferred← citeshttps://doi.org/10.3390/jcm12041436openalex-snapshot
Pediatric Laryngopharyngeal Reflux in the Last Decade: What Is New and Where to Next?
inferred← citeshttps://doi.org/10.5152/tjg.2019.19677openalex-snapshot
Alginates: From the ocean to gastroesophageal reflux disease treatment
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.